Clinical Trial Update: A Single Arm, Prospective, Open Label, Multi Center, Phase Ib Study to Evaluate the Safety, Tolerability and Initial Efficacy of a Single Intra-tumoral Injection of IntraGel's Polymer-based Cisplatin-loaded Gel (TumoCure) in Subjects With Progressive or Radio-resistant Primary Head and Neck Tumor [Phase 1]

View source ↗

Summary

Phase 1, single-arm, open-label multicenter trial to assess safety, tolerability, and initial efficacy of a single intra-tumoral injection of TumoCure, a cispla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• TumoCure (cisplatin-loaded polymer-based gel)

Snippet

Sponsor: IntraGel Therapeutics | Conditions: Head and Neck Cancer | Phase 1 | Status: RECRUITING